Prostaglandin-producing suppressor cells in Hodgkin's disease
- PMID: 409950
- DOI: 10.1056/NEJM197711032971802
Prostaglandin-producing suppressor cells in Hodgkin's disease
Abstract
We examined the role of a prostaglandin-producing suppressor cell in the hyporesponsiveness to phytohemagglutinin seen in Hodgkin's disease. Addition of indomethacin to phytohemagglutinin cultures of lymphocytes from six patients with Hodgkin's disease resulted in an increase of 182 +/- 60 per cent in 3H-thymidine incorporation versus a 44 +/- 18% increase in 29 controls (mean +/- S.D., P less than 0.001). Without indomethacin the mean response of the lymphocytes in Hodgkin's disease was 48% of that of control. With indomethacin it was 94% of the control value. Phytohemagglutinin cultures of Hodgkin-disease lymphocytes produced approximately fourfold more prostaglandin E2 after 48 hours than did normal lymphocytes (P less than 0.02). Removal of glass-adherent cells markedly decreased the enhancement seen with indomethacin; it reduced prostaglandin E2 production by more than 80% and eliminated the differences in response to phytohemagglutinin between Hodgkin-disease and normal lymphocytes. Thus, a glass-adherent, prostaglandin-producing suppressor cell is responsible for the hyporesponsiveness to phytohemagglutinin seen with Hodgkin-disease lymphocytes.
Similar articles
-
Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.J Immunol. 1982 Oct;129(4):1770-4. J Immunol. 1982. PMID: 6980949
-
Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.J Clin Invest. 1978 Oct;62(4):753-60. doi: 10.1172/JCI109186. J Clin Invest. 1978. PMID: 701474 Free PMC article.
-
Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.J Clin Invest. 1978 Jan;61(1):55-63. doi: 10.1172/JCI108925. J Clin Invest. 1978. PMID: 304068 Free PMC article.
-
Suppressor monocytes in human disease: a review.Adv Exp Med Biol. 1979;121B:283-98. doi: 10.1007/978-1-4684-8914-9_27. Adv Exp Med Biol. 1979. PMID: 161850 Review.
-
The nature and function of the Hodgkin's cell lectin and its role in lymphocyte agglutination.Int Rev Exp Pathol. 1992;33:115-40. doi: 10.1016/b978-0-12-364933-1.50010-2. Int Rev Exp Pathol. 1992. PMID: 1733869 Review. No abstract available.
Cited by
-
The distribution of iron and iron binding proteins in spleen with reference to Hodgkin's disease.Br J Cancer. 1986 Aug;54(2):277-86. doi: 10.1038/bjc.1986.174. Br J Cancer. 1986. PMID: 3741763 Free PMC article.
-
Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.Cancer Immunol Immunother. 1990;32(4):256-60. doi: 10.1007/BF01741710. Cancer Immunol Immunother. 1990. PMID: 2261600 Free PMC article.
-
The effect of human monocytes and macrophages on lymphocyte proliferation.Immunology. 1982 Sep;47(1):175-81. Immunology. 1982. PMID: 6956545 Free PMC article.
-
Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.Br J Cancer. 1982 Jan;45(1):70-9. doi: 10.1038/bjc.1982.9. Br J Cancer. 1982. PMID: 6977367 Free PMC article.
-
Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma.Cancer Immunol Immunother. 1987;25(2):126-32. doi: 10.1007/BF00199952. Cancer Immunol Immunother. 1987. PMID: 3478137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources